Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

June 9, 2023

Study Completion Date

June 9, 2023

Conditions
HIV-1 Infection
Interventions
OTHER

Samplings

"* blood samples~* rectal biopsies~* nodes biopsies~* cutaneous fat tissues biopsies~* semen sample"

Trial Locations (8)

59208

Tourcoing Hospital, Tourcoing

75012

Saint Antoine Hospital, Paris

Unknown

Antoine-Beclere Hospital, Clamart

Bicetre Hospital, Le Kremlin-Bicêtre

Bichat Hospital, Paris

Hotel Dieu Hospital, Paris

Necker Hospital, Paris

Pitie Salpetriere Hospital, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ViiV Healthcare

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV